1. Feasibility of Fine-Needle Aspiration Biopsy and Rapid On-Site Evaluation for Immediate Triage in Breast Cancer Screening in Tanzania
- Author
-
Asteria Kimambo, Katherine Van Loon, Godfrey Sama Philipo, Elia John Mmbaga, Edda Vuhahula, and Dianna Ng
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Adolescent ,Biopsy, Fine-Needle ,Early detection ,Breast Neoplasms ,Site evaluation ,Tanzania ,03 medical and health sciences ,Breast cancer screening ,Young Adult ,0302 clinical medicine ,Breast cancer ,Biopsy ,Breast Cancer ,medicine ,Humans ,030212 general & internal medicine ,Early Detection of Cancer ,Aged ,medicine.diagnostic_test ,biology ,business.industry ,ORIGINAL REPORTS ,Middle Aged ,medicine.disease ,biology.organism_classification ,Triage ,Fine-needle aspiration ,Oncology ,030220 oncology & carcinogenesis ,Feasibility Studies ,Female ,Radiology ,business - Abstract
PURPOSE Clinical breast examination (CBE) is one of the most common methods used for early detection of breast cancer in low- and middle-income countries. CBE alone is limited by lack of specificity and may result in unnecessary diagnostic procedures. We evaluated the feasibility of integrating CBE, fine-needle aspiration biopsy (FNAB), and rapid on-site evaluation (ROSE) in triaging palpable breast masses for specialized cancer care. MATERIALS AND METHODS An intensive breast cancer screening event was conducted at a national trade fair by a multidisciplinary team of care providers targeting a healthy population in Dar es Salaam, Tanzania. All adults age ≥ 18 years were invited to participate. CBE was performed by oncologists and/or pathologists. FNAB was performed by a pathologist on palpable masses that were then categorized as benign, indeterminate, or suspicious for malignancy or definitively malignant based on ROSE. RESULTS A total of 208 individuals (207 females, one male; median age, 36 years; range, 18-68 years) were screened. Most (90.8%, 189 of 208) had normal findings, whereas 7.2% (15 of 208), 1% (2 of 208), and 1% (2 of 208) had a palpable mass, breast pain, and nipple discharge, respectively. Two participants had lesions too small for palpation-guided biopsy and clinically consistent with fibroadenomas; the participants were counseled, and observation was recommended. FNAB was performed on 13 breast masses, with 9 of 13 (69%) categorized as benign and 4 of 13 (31%) suspicious for malignancy. Final cytopathologic review of referred patients confirmed one case to be breast adenocarcinoma, one was suggestive of fibroadenoma, and two showed inflammations. CONCLUSION Integration of CBE with ROSE and FNAB was feasible in a breast cancer screening program in Tanzania. In settings with constrained resources for cancer care, this may be an effective method for triaging patients with breast masses.
- Published
- 2021